Table 5 Meta-analyses of correlation between downregulated tsRNAs and clinicopathological features of breast cancer
From: Prognostic, diagnostic and clinicopathological roles of tsRNAs: a meta-analysis in breast cancer
Downregulated tsRNAs | No. of studies | No. of patients | Odds ratio (95%CI) | p-value | Heterogeneity | I2 (%) |
|---|---|---|---|---|---|---|
Age (≤ 50/ > 50) | 3 | 92 | 2.470 (1.067–5.718) | 0.361 | 2.04 | 1.8 |
TNM stage (I-II/III-IV) | 3 | 92 | 3.435 (1.468–8.039) | 0.304 | 2.38 | 16.0 |
Lymphatic metastasis ( ±) | 4 | 136 | 0.354 (0.177–0.709) | 0.038 | 8.42 | 64.4 |